Internal Moderna Report Tags Elon Musk, Novak Djokovic, and Russell Brand as ‘High Risk’
Moderna (NASDAQ: MRNA), the Boston-based pharmaceutical company known for its mRNA Covid-19 vaccine, has reportedly enlisted the services of former
Read more
mRNA
Moderna and Merck & Co: mRNA Cancer Vaccine Shows “Highly Encouraging Results,” Shares Rise
On Tuesday, Moderna (NASDAQ: MRNA) announced that their personalized cancer-vaccine program was successful in a midstage study of skin-cancer patients.
Read more